标题
Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease
作者
关键词
-
出版物
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 330, Issue 6, Pages 507
出版商
American Medical Association (AMA)
发表日期
2023-07-17
DOI
10.1001/jama.2023.11703
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anti-amyloid antibody therapies in Alzheimer's disease
- (2023) Robert Perneczky et al. BRAIN
- Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke
- (2023) Nicholas J. Reish et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brain Shrinkage in Anti–β-Amyloid Alzheimer Trials
- (2023) Frederik Barkhof et al. NEUROLOGY
- Donanemab in Early Symptomatic Alzheimer Disease
- (2023) John R. Sims et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US
- (2022) Eric L. Ross et al. JAMA Neurology
- Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes
- (2022) Sergey Shcherbinin et al. JAMA Neurology
- Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease
- (2022) Michael J. Pontecorvo et al. JAMA Neurology
- Lecanemab in Early Alzheimer’s Disease
- (2022) Christopher H. van Dyck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
- (2021) Chad J. Swanson et al. Alzheimers Research & Therapy
- Controversy and Progress in Alzheimer’s Disease — FDA Approval of Aducanumab
- (2021) Gil D. Rabinovici NEW ENGLAND JOURNAL OF MEDICINE
- Treatments for Alzheimer's disease emerge
- (2021) Dennis J. Selkoe SCIENCE
- Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
- (2021) Stephen Salloway et al. JAMA Neurology
- Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease
- (2020) Erik S. Musiek et al. JAMA Neurology
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now